Home/Pipeline/Companion Diagnostic Development

Companion Diagnostic Development

Various (for pharmaceutical partners)

DevelopmentService Offering

Key Facts

Indication
Various (for pharmaceutical partners)
Phase
Development
Status
Service Offering
Companies

About Genetic Analysis

Genetic Analysis AS is a diagnostic company focused on unlocking the potential of the human microbiome through its proprietary GA-map® technology platform. A key achievement is the commercialization of the world's first CE-marked IVD test for gut dysbiosis in IBS and IBD, which has been used in over 50 clinical trials. The company is strategically expanding its product portfolio with research-use assays like the MHI GutHealth test, developed with Ferring Pharmaceuticals, and pursuing opportunities in companion diagnostics to support pharmaceutical development.

View full company profile

About Genomic Testing Cooperative

Founded in 2018, Genomic Testing Cooperative is a commercial-stage diagnostics company focused on delivering comprehensive genomic profiling for oncology. Its core differentiators are a cooperative business model, a fully integrated NGS platform analyzing both DNA and RNA, and a strong emphasis on rapid turnaround times, averaging under 7 days for DNA tests. GTC's offerings include tissue-based panels and its Liquid Trace® liquid biopsy test, supported by proprietary AI-driven informatics for data interpretation.

View full company profile

About Leica Biosystems

Leica Biosystems, founded in 1990 and headquartered in Buffalo Grove, USA, is a major player in the diagnostics and medical device sectors, specializing in comprehensive anatomic pathology workflows. The company leverages over 150 years of heritage (through its parent and legacy brands) to offer a fully integrated portfolio including histology instruments, immunohistochemistry (IHC) stainers, digital pathology scanners, and specimen tracking software. As a commercial-stage, revenue-generating entity, it serves laboratories and research institutions worldwide, aiming to standardize and digitize pathology to enhance diagnostic confidence and operational efficiency. It operates as a private company, a subsidiary of Danaher Corporation.

View full company profile